As a result, indirect contextual factors often remain overlooked in evaluations
Reduced effectiveness for the primary health condition Semaglutide is primarily used for managing blood glucose levels in patients with type 2 diabetes
a Clinicaltrials.gov identifier ( Table 2 Summary of Clinical Trials in Which the Cardiovascular Effects of GLP-1 RAs Were Non-Primary Outcomes GLP-1 RA, glucagon-like peptide-1 receptor agonist

To maximise treatment effectiveness, consider implementing these evidence-based strategies: Choose a convenient, memorable day for your weekly injectionmany patients select the same day they attend religious services, do weekly shopping, or have other regular commitments Prepare your injection supplies in advance , ensuring you have alcohol swabs, a sharps container, and your Ozempic pen readily accessible Rotate injection sites systematically between your abdomen, thigh, or upper arm to reduce the risk of injection-site reactions and maintain consistent absorption [1] [2] Monitor your blood glucose levels as recommended by your healthcare team, keeping a record to identify patterns and assess treatment effectiveness Attend regular follow-up appointments with your GP or diabetes specialist nurse for ongoing assessment, dose adjustments, and HbA1c monitoring According to NICE guidelines for type 2 diabetes management (NG28), GLP-1 receptor agonists like Ozempic should be continued only if they produce beneficial metabolic responses when used for type 2 diabetes, typically defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight at six months
